VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 60 filers reported holding VOR BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,486,853 | -31.4% | 6,361,723 | 0.0% | 3.88% | -20.7% |
| Q2 2023 | $19,657,724 | -42.6% | 6,361,723 | 0.0% | 4.90% | -44.1% |
| Q1 2023 | $34,226,070 | -19.1% | 6,361,723 | 0.0% | 8.75% | -23.0% |
| Q4 2022 | $42,305,458 | +67.1% | 6,361,723 | 0.0% | 11.37% | +134.4% |
| Q3 2022 | $25,320,000 | -19.9% | 6,361,723 | 0.0% | 4.85% | -38.0% |
| Q2 2022 | $31,618,000 | -17.7% | 6,361,723 | 0.0% | 7.82% | -6.8% |
| Q1 2022 | $38,425,000 | -48.0% | 6,361,723 | 0.0% | 8.39% | -39.5% |
| Q4 2021 | $73,923,000 | -29.6% | 6,361,723 | -4.9% | 13.88% | -34.9% |
| Q3 2021 | $104,937,000 | -15.9% | 6,692,429 | 0.0% | 21.31% | -32.2% |
| Q2 2021 | $124,814,000 | -56.7% | 6,692,429 | 0.0% | 31.41% | -39.5% |
| Q1 2021 | $288,444,000 | – | 6,692,429 | – | 51.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,692,429 | $288,444,000 | 51.94% |
| Trustees of Columbia University in the City of New York | 183,821 | $7,923,000 | 9.60% |
| RA Capital Management | 11,120,973 | $479,314,000 | 7.23% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,074,658 | $46,318,000 | 6.00% |
| Sarissa Capital Management LP | 707,010 | $30,472,000 | 2.92% |
| SECTORAL ASSET MANAGEMENT INC | 535,259 | $23,070,000 | 1.75% |
| Woodline Partners LP | 1,153,267 | $49,706,000 | 1.10% |
| Artal Group S.A. | 550,000 | $23,705,000 | 0.42% |
| Orbimed Advisors | 833,333 | $35,917,000 | 0.34% |
| Laurion Capital Management LP | 585,667 | $25,242,000 | 0.14% |